Tải xuống
Tóm tắt
Background: Intensity-modulated radiotherapy with concurrent chemotherapy attempt to maintain efficiency while limiting toxicity in the treatment of neck squamous cell carcinomas. Side effects of the therapy are both challenge during treatment such as treatment delay, increasing financial and hospitalization rate and also cause early and late toxicities, affects to patient performances and treatment outcomes. We aimed to assess acute and late toxicity in patients with head and neck squamous cell carcinoma (HNSCC) managed with concurrent chemoradiation therapy using intensity modulated radiation therapy (IMRT) technique.
Methods: A prospective descriptive study of 120 patients suffering from non-metastatic HNSCC received Intensity-modulated radiotherapy concurrently with four to six cycles of cisplatin (30mg/m2/day/
weekly)from May 2017 to 2018 at Hue Central Hospital (Vietnam). The dose to the primary tumour and cervical lymph nodes totally taken was 70 Gy. Toxicities were gradedbased on the European Organization for Research and Treatment of Cancer (EORTC) and the Radiation Therapy Oncology Group (RTOG).
Results: Acute toxicities were mainly at grade 1 with oral mucositis, dermatitis and nausea/vomiting. For late toxicities, grade 3 xerostomia accountings for 5.8%. Neck fibrosis and trismus were not at grade 3
to grade 4, grade 1 mandibular bone necrosis (3.4%) was found in 3 patients.
Conclusions: Concurrent chemoradiation therapy with IMRT demonstrated a well-tolerated regime with manageable toxicities.
Keywords: Intensity-modulated radiation, Chemotherapy, Toxicity
Tài liệu tham khảo
Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020;6:92
Hunter K, Parkinson EK, Thakker N. An overview of the molecular pathology of head and neck cancer, and its clinical implications.
Periodontol 2000 2011;57:132-49
Yeh SA. Radiotherapy for head and neck cancer. Semin Plast Surg 2010;24:127-36
Cho B. Intensity-modulated radiation therapy: a review with a physics perspective. Radiat Oncol J 2018;36:1-10
Brook I. Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J 2020;38:84-92
Majeed H, Gupta V, Adverse Effects Of Radiation Therapy, in StatPearls. 2021: Treasure Island (FL).
Ozdemir S, Akin M, Coban Y, Yildirim C, Uzel O. Acute toxicity in nasopharyngeal carcinoma patients treated with IMRT/VMAT. Asian Pac J Cancer Prev 2015;16:1897-900
Songthong A, Chakkabat C, Kannarunimit D, Lertbutsayanukul C. Efficacy of intensitymodulated radiotherapy with concurrent
carboplatin in nasopharyngeal carcinoma. Radiol Oncol 2015;49:155-62
Van Gestel D, Van Den Weyngaert D, Schrijvers D, Weyler J, Vermorken JB. Intensity-modulated radiotherapy in patients with head and neck cancer: a European single-centre experience. Br J Radiol 2011;84:367-74
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, et al. Preliminary results of Radiation Therapy Oncology Group 97-03: a randomized phase ii trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. J Clin Oncol 2004;22:2856-64
Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for
nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009;27:3684-90
Wang J, Shi M, Hsia Y, Luo S, Zhao L, Xu M, et al. Failure patterns and survival in patients with nasopharyngeal carcinoma treated with intensity modulated radiation in Northwest China: a pilot study. Radiat Oncol 2012;7:2
Pan XB, Chen KH, Huang ST, Jiang YM, Ma JL, Liang ZG, et al. Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma. Oncotarget 2017;8:78096-78104
Zheng Y, Han F, Xiao W, Xiang Y, Lu L, Deng X, et al. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy. Radiat Oncol 2015;10:17
Marta GN, Silva V, de Andrade Carvalho H, de Arruda FF, Hanna SA, Gadia R, et al. Intensitymodulated radiation therapy for head and neck cancer: systematic review and meta-analysis. Radiother Oncol 2014;110:9-15
De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L, et al. Follow-up program in head and neck cancer. Crit Rev Oncol Hematol 2017;113:151-155
Chen QY, Wen YF, Guo L, Liu H, Huang PY, Mo HY, et al. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 2011;103:1761-70
| Đã xuất bản | 13-01-2025 | |
| Toàn văn |
|
|
| Ngôn ngữ |
|
|
| Số tạp chí | Số 69 (2021) | |
| Phân mục | Nghiên cứu | |
| DOI | 10.38103/jcmhch.2021.69.8 | |
| Từ khóa | Keywords: Intensity-modulated radiation, Chemotherapy, Toxicity. |
công trình này được cấp phép theo Creative Commons Attribution-phi thương mại-NoDerivatives 4.0 License International .
Bản quyền (c) 2021 Tạp chí Y học lâm sàng Bệnh viện Trung Ương Huế